Medical Device News Magazine

Ethicon Surgical Innovations Lab Kicks Off: Benefits Surgeons Unable to Travel

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Ethicon*, part of the Johnson & Johnson Medical Devices Companies**, today announced its state-of-the-art and fully functional surgical lab on wheels will travel to hospitals in 70 locations across America providing surgeons and other healthcare professionals the opportunity for hands-on learning experiences and demonstrations with the newest technologies for colorectal, bariatric, gynecological and thoracic procedures.

ethicon

The Ethicon Surgical Innovations Lab will showcase the company’s portfolio of advanced energy solutions including the recently launched ENSEAL X1 Curved Jaw Tissue Sealer, which continuously senses changes in tissue and responds with the optimized amount of energy during surgery.[i]

The groundbreaking ECHELON CIRCULAR Powered Stapler will also be among the surgical stapler technology featured on the more than 850-square-foot mobile lab. In recent studies, the ECHELON CIRCULAR, which is the world’s first circular powered stapler, has been shown to reduce anastomotic leaks, a relatively common and potentially life-threatening complication of colorectal surgery, by nearly 74% compared to manual circular staplers.[ii] Surgical staplers utilize specialized staples to close off and cut through organs, tissue and blood vessels in both laparoscopic and traditional surgery.

“After a year like no other, we’re eager to bring these latest advances directly to surgeons in their own communities and continue building on our trusted legacy of innovation to shape the future of surgery,” said Nefertiti Greene, President, US Ethicon. “Ethicon has a significant research, development and educational focus on improving patient outcomes, reducing life-threatening and costly complications, and streamlining surgery through innovations in surgical stapling technology and energy-based devices.”

Over the last year, the COVID-19 pandemic has limited opportunities for surgeons and other practitioners to travel for in-person learning experiences. The Ethicon Surgical Innovations Lab mobile tour is being conducted to help surgeons and hospitals stay current on the latest technologies and the science behind them from the convenience of their own cities. Surgeons will be able to use the various devices on inanimate tissue and engage with key faculty, engineers and researchers on the technical aspects of the products, as well as the body of evidence that supports them.

The Ethicon Surgical Innovation Lab was recently in Dayton, Ohio at Kettering Health for one of its first stops on the national tour.

“The mobile lab was an amazing experience. The benefit for our surgeons and staff to be able to get hands-on training and education cannot be measured. I encourage anyone who has the opportunity to visit the lab to definitely do so. We walked away with very valuable knowledge and understanding of the new technology being offered. Definitely a must see for clinicians and staff,” said Jerry Willis, Strategic Sourcing Manager Surgical Services, Kettering Health.

[i]Claim #134168-210203

[ii]Sylla, P., Sagar, P., Johnston, S.S. et al. Outcomes associated with the use of a new powered circular stapler for left-sided colorectal reconstructions: a propensity score matching-adjusted indirect comparison with manual circular staplers. Surg Endosc(2021). https://doi.org/10.1007/s00464-021-08542-7


[1]Claim #134168-210203

[1]Sylla, P., Sagar, P., Johnston, S.S. et al. Outcomes associated with the use of a new powered circular stapler for left-sided colorectal reconstructions: a propensity score matching-adjusted indirect comparison with manual circular staplers. Surg Endosc(2021). https://doi.org/10.1007/s00464-021-08542-7

*Ethicon represents the products and services of Ethicon, Inc., Ethicon Endo-Surgery, LLC and certain of their affiliates. All other trademarks are the property of their respective owners.

**The Johnson & Johnson Medical Devices Companies comprise the surgery, orthopedics, and interventional solutions businesses within Johnson & Johnson’s Medical Devices segment.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”